Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARBK NASDAQ:BTCS NASDAQ:NRBO NASDAQ:WVFC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARBKArgo Blockchain$0.32+1.9%$0.34$0.15▼$1.55$23.10M1.786.93 million shs911,122 shsBTCSBTCS$5.00+11.1%$3.68$0.95▼$8.49$239.25M1.1713.01 million shs9.56 million shsNRBONeuroBo Pharmaceuticals$0.63-1.0%$0.68$2.08▼$4.41$5.43M-0.2639,605 shs60,809 shsWVFCWVS Financial$12.26$12.32$12.01▼$13.60$23.22M0.09840 shsN/A(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARBKArgo Blockchain0.00%+9.30%+5.94%-10.08%-73.25%BTCSBTCS0.00%+23.15%+10.38%+139.23%+284.62%NRBONeuroBo Pharmaceuticals0.00%+3.43%-8.84%-13.59%-82.50%WVFCWVS Financial0.00%+0.82%-1.92%-0.33%+1.16%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARBKArgo Blockchain0.7339 of 5 stars0.03.00.00.03.30.00.6BTCSBTCS1.0938 of 5 stars1.52.00.00.03.92.50.0NRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AWVFCWVS Financial1.1756 of 5 stars0.03.01.70.00.00.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARBKArgo Blockchain 1.50ReduceN/AN/ABTCSBTCS 3.00Buy$5.00N/ANRBONeuroBo Pharmaceuticals 0.00N/AN/AN/AWVFCWVS Financial 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARBKArgo Blockchain$47.02M0.49N/AN/A($0.41) per share-0.78BTCSBTCS$4.07M58.78N/AN/A$1.84 per share2.72NRBONeuroBo PharmaceuticalsN/AN/AN/AN/A$1.50 per shareN/AWVFCWVS Financial$5.13M4.52$0.55 per share22.45$19.93 per share0.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARBKArgo Blockchain-$55.10M-$0.97N/AN/AN/A-117.38%N/A-79.90%8/27/2025 (Estimated)BTCSBTCS-$1.27M-$1.71N/AN/AN/A-579.87%-41.76%-35.70%8/18/2025 (Estimated)NRBONeuroBo Pharmaceuticals-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%8/12/2025 (Estimated)WVFCWVS Financial$1.38M$1.0512.51∞N/A9.50%12.31%1.29%N/ALatest NRBO, BTCS, ARBK, and WVFC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/18/2025N/ABTCSBTCS-$0.07N/AN/AN/A$1.70 millionN/A5/22/2025Q4 2024ARBKArgo Blockchain-$0.14-$0.15-$0.01-$0.27$7.99 millionN/A5/15/2025Q1 2025BTCSBTCSN/A-$0.14N/A-$0.86N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARBKArgo BlockchainN/AN/AN/AN/AN/ABTCSBTCSN/AN/AN/AN/AN/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/AWVFCWVS Financial$0.403.26%N/A38.10%N/ALatest NRBO, BTCS, ARBK, and WVFC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/5/2025WVFCWVS Financial$0.103.29%8/11/20258/12/20258/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARBKArgo BlockchainN/A1.241.24BTCSBTCSN/A43.4443.44NRBONeuroBo PharmaceuticalsN/A2.412.41WVFCWVS Financial3.200.530.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARBKArgo Blockchain2.42%BTCSBTCS3.48%NRBONeuroBo Pharmaceuticals1.37%WVFCWVS Financial6.31%Insider OwnershipCompanyInsider OwnershipARBKArgo BlockchainN/ABTCSBTCS42.80%NRBONeuroBo Pharmaceuticals1.05%WVFCWVS Financial13.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARBKArgo Blockchain4071.95 million71.95 millionOptionableBTCSBTCS447.85 million27.37 millionNot OptionableNRBONeuroBo Pharmaceuticals108.62 million8.53 millionNot OptionableWVFCWVS Financial201.89 million1.64 millionNot OptionableNRBO, BTCS, ARBK, and WVFC HeadlinesRecent News About These CompaniesWVFC WVS Financial Corp.August 25, 2024 | seekingalpha.comWVS Financial Corp. (WVFC)March 15, 2024 | finance.yahoo.comWVS Financial Corp.February 17, 2024 | wsj.comWVS Financial (WVFC) Earnings Dates & ReportsDecember 17, 2023 | investing.comWVFC Historical DataOctober 18, 2023 | investing.comMore efforts underway to fully fund West Virginia State UniversityOctober 3, 2023 | msn.comWVS Financial (WVFC) Declares $0.10 DividendApril 27, 2023 | msn.comUBS AG (UBS): Today's Featured Banking LaggardMarch 31, 2023 | thestreet.comNorth American Morning Briefing: Stocks to Gain -2-August 25, 2022 | morningstar.comMOTC Markets Group Welcomes WVS Financial Corp. to OTCQXJune 13, 2022 | finance.yahoo.comWVS Financial Corp. to delist from NasdaqMay 24, 2022 | finance.yahoo.comDo These 3 Checks Before Buying WVS Financial Corp. (NASDAQ:WVFC) For Its Upcoming DividendMay 1, 2022 | finance.yahoo.comWVS Financial goes ex dividend tomorrowFebruary 3, 2022 | seekingalpha.comNew York Community Bancorp Inc. (NYSE: NYCB): Finding Hidden Gems Among VolatilityJanuary 5, 2022 | stocksregister.comSNew York Community Bancorp Inc. (NYSE: NYCB) Stock: Up 15.74% From Low, Just WaitDecember 15, 2021 | stocksregister.comSWVS Financial's (NASDAQ:WVFC) Dividend Will Be US$0.10November 1, 2021 | finance.yahoo.comNew York Community Bancorp Inc. (NYCB): At $12.82, It’s Worth Your AttentionOctober 28, 2021 | stocksregister.comSWVS FINANCIAL CORP. ANNOUNCES QUARTERLY CASH DIVIDEND - Form 8-KOctober 26, 2021 | publicnow.comAt $13.93 Price, New York Community Bancorp Inc. (NYCB) Is Sitting And WaitingOctober 21, 2021 | stocksregister.comSAre Investors Interested In Selling Their Holdings Of New York Community Bancorp Inc. (NYSE: NYCB)?October 20, 2021 | stocksregister.comSNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNRBO, BTCS, ARBK, and WVFC Company DescriptionsArgo Blockchain NASDAQ:ARBK$0.32 +0.01 (+1.90%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.31 -0.01 (-2.49%) As of 08/8/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Argo Blockchain plc, together with its subsidiaries, engages in the bitcoin and other cryptocurrencies mining business worldwide. It engages in mining purpose-built computers for complex cryptographic algorithms. The company was formerly known as GoSun Blockchain Limited and changed its name to Argo Blockchain plc in December 2017. Argo Blockchain plc was incorporated in 2017 and is based in London, the United Kingdom.BTCS NASDAQ:BTCS$5.00 +0.50 (+11.11%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$5.00 +0.00 (+0.08%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BTCS Inc. operates in blockchain technology sector the United States. Its blockchain-infrastructure secures and operates validator nodes on disruptive blockchain networks, as well as validates transactions for crypto holding delegations on dPoS blockchains. The company offers StakeSeeker, a cryptocurrency dashboard and staking-as-a-service platform that allows crypto asset holders to earn rewards by participating in network consensus mechanisms; and Builder+, a Ethereum block builder offered to maximize validator earnings by utilizing algorithms to construct optimized blocks for on-chain validation. In addition, it is involved in the development of ChainQ, an AI-powered blockchain data and analytics platform, which allows users to query real-time and historical on-chain blockchain data. The company was formerly known as Bitcoin Shop, Inc. and changed its name to BTCS Inc. in July 2015. BTCS Inc. was founded in 2014 and is based in Silver Spring, Maryland.NeuroBo Pharmaceuticals NASDAQ:NRBO$0.63 -0.01 (-1.01%) As of 08/8/2025NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.WVS Financial NASDAQ:WVFC$12.26 0.00 (0.00%) As of 08/8/2025WVS Financial Corp. operates as the bank holding company for West View Savings Bank that provides various banking products and services in the United States. The company accepts various deposit products, including regular savings accounts, demand accounts, negotiable order of withdrawal accounts, money market deposit accounts, and certificates of deposit, as well as individual retirement account certificates. It also offers single-family and multi-family residential real estate loans, commercial real estate loans, construction loans, consumer loans, land acquisition and development loans, and commercial loans. In addition, the company is involved in the investment activities. WVS Financial Corp. was founded in 1908 and is based in Pittsburgh, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale